Vitamin B12 intake and status and cognitive function in elderly people

Epidemiologic Reviews

Volumn 35, Issue 1, 2013, Pages 2-21

  Doets, Esmée L ^a   Van Wijngaarden, Janneke P ^a   Szczecińska, Anna ^b   Dullemeijer, Carla ^a   Souverein, Olga W ^a   Dhonukshe Rutten, Rosalie A M ^a   Cavelaars, Adrienne E J M ^a   Van'T Veer, Pieter ^a   Brzozowska, Anna ^b   De Groot, Lisette C P G M ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

aged; cognition; dementia; nutritional requirements; recommended dietary allowances; review

Indexed keywords

CYANOCOBALAMIN; METHYLMALONIC ACID; TRANSCOBALAMIN;

AGED; ALZHEIMER DISEASE; ARTICLE; COGNITION; COHORT ANALYSIS; DEMENTIA; DOSE RESPONSE; HUMAN; META ANALYSIS (TOPIC); MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; VITAMIN INTAKE; WECHSLER MEMORY SCALE; BLOOD; COGNITION DISORDERS; DIET; METABOLISM; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COGNITION; COGNITION DISORDERS; DEMENTIA; DIET; HUMANS; METHYLMALONIC ACID; TRANSCOBALAMINS; VITAMIN B 12;

EID: 84874453926     PISSN: 0193936X     EISSN: 14786729     Source Type: Journal    
DOI: 10.1093/epirev/mxs003     Document Type: Article

References (84)

1. Aggett PJ. Nutrient risk assessment: setting upper levels and an opportunity for harmonization. Food Nutr Bull. 2007; 28(suppl 1):S27-S37.
2. Dhonukshe-Rutten RAM, Timotijevic L, Cavelaars A, et al. European micronutrient recommendations aligned: a general framework developed by EURRECA. Eur J Clin Nutr. 2010;64(suppl 2):S2-S10.
3. 12, iron and zinc for adults and elderly people. Public Health Nutr. 2012;15(5):906-915.
4. Atkinson SA, Koletzko B. Determining life-stage groups and extrapolating nutrient intake values (NIVs). Food Nutr Bull. 2007;28(suppl 1):S61-S76.
5. Russell R, Chung M, Balk EM, et al. Opportunities and challenges in conducting systematic reviews to support the development of nutrient reference values: vitamin A as an example. Am J Clin Nutr. 2009;89(3):728-733.
6. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008- 2012.
7. 12, and folic acid supplementation and cognitive function: a systematic review of randomized trials. Arch Intern Med. 2007; 167(1):21-30.
8. Ellinson M, Thomas J, Patterson A. A critical evaluation of the relationship between serum vitamin B-12, folate and total homocysteine with cognitive impairment in the elderly. J Hum Nutr Diet. 2004;17(4):371-383.
9. 12 for cognition. Cochrane Database Syst Rev. 2003;3:CD004326. (doi: 10.1002/14651858).
10. Raman G, Tatsioni A, Chung M, et al. Heterogeneity and lack of good quality studies limit association between folate, vitamins B-6 and B-12, and cognitive function. J Nutr. 2007;137(7):1789-1794.
11. 12, folate and cognitive functions: a systematic and critical review of the literature. Int J Clin Pract. 2009; 63(7):1061-1067.
12. Wald DS, Kasturiratne A, Simmonds M. Effect of folic acid, with or without other B vitamins, on cognitive decline: meta-analysis of randomized trials. Am J Med. 2010; 123(6):522-527.
13. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198.
14. 12, holotranscobalamin. Clin Chem. 2007;53(5):963-970.
15. Hoey L, Strain JJ, McNulty H. Studies of biomarker responses to intervention with vitamin B-12: a systematic review of randomized controlled trials. Am J Clin Nutr. 2009;89(6):1981S-1996S.
16. Nexo E, Hoffmann-Lucke E. Holotranscobalamin, a marker of vitamin B-12 status: analytical aspects and clinical utility. Am J Clin Nutr. 2011;94(1):359S-365S.
17. 12 status in the elderly. Clin Chem. 2011;57(6):856-863.
18. Higgins JPT, Green S, eds. Cochrane Handbook for System-atic Reviews of Interventions, Version 5.1.0 (updated March 2011). Oxford, United Kingdom: The Cochrane Collaboration; 2011. (www.cochrane-handbook.org). (Accessed August 21, 2012).
19. Corrada MM, Kawas CH, Hallfrisch J, et al. Reduced risk of Alzheimer's disease with high folate intake: the Baltimore Longitudinal Study of Aging. Alzheimers Dement. 2005; 1(1):1118.
20. Morris MC, Evans DA, Schneider JA, et al. Dietary folate and vitamins B-12 and B-6 not associated with incident Alzheimer's disease. J Alzheimers Dis. 2006;9(4):435-443.
21. Nelson C, Wengreen HJ, Munger RG, et al. Dietary folate, vitamin B-12, vitamin B-6 and incident Alzheimer's disease: the Cache County Memory, Health and Aging Study. J Nutr Health Aging. 2009;13(10):899-905.
22. Haan MN, Miller JW, Aiello AE, et al. Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging. Am J Clin Nutr. 2007;85(2):511-517.
23. 12 and homocysteine associated with incident dementia. J Neurol Neurosurg Psychiatry. 2008;79(8):864-868.
24. Ravaglia G, Forti P, Maioli F, et al. Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr. 2005;82(3):636-643.
25. 12 and folate in relation to the development of Alzheimer's disease. Neurology. 2001;56(9):1188-1194.
26. 12 levels and incidence of dementia in a healthy elderly population: a report from the Bronx Longitudinal Aging Study. J Am Geriatr Soc. 1994;42(9):933-936.
27. 12 status and cerebral white-matter lesions. J Neurol Neurosurg Psychiatry. 2009;80(2):149-157.
28. Morris MC, Evans DA, Bienias JL, et al. Dietary folate and vitamin B-12 intake and cognitive decline among community-dwelling older persons. Arch Neurol. 2005;62(4):641-645.
29. Clarke R, Birks J, Nexo E, et al. Low vitamin B-12 status and risk of cognitive decline in older adults. Am J Clin Nutr. 2007;86(5):1384-1391.
30. Mooijaart SP, Gussekloo J, Frolich M, et al. Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus Study. Am J Clin Nutr. 2005;82(4):866-871.
31. Tangney CC, Tang Y, Evans DA, et al. Biochemical indicators of vitamin B(12) and folate insufficiency and cognitive decline. Neurology. 2009;72(4):361-367.
32. Feng L, Li JL, Yap KB, et al. Vitamin B-12, apolipoprotein E genotype, and cognitive performance in community-living older adults: evidence of a gene-micronutrient interaction. Am J Clin Nutr. 2009;89(4):1263-1268.
33. Tucker KL, Qiao N, Scott T, et al. High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am J Clin Nutr. 2005;82(3):627-635.
34. 12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging. Am J Med. 2005;118(2):161-167.
35. 12, and cognitive function and decline. Epidemiology. 2006;17(6):650-657.
36. 12 /folate status of elderly Europeans. J Nutr Health Aging. 2002;6(1):43-50.
37. Kim JM, Kim SW, Shin IS, et al. Folate, vitamin B(12), and homocysteine as risk factors for cognitive decline in the elderly. Psychiatry Investig. 2008;5(1):36-40.
38. La Rue A, Koehler KM, Wayne SJ, et al. Nutritional status and cognitive functioning in a normally aging sample: a 6-y reassessment. Am J Clin Nutr. 1997;65(1):20-29.
39. Nurk E, Refsum H, Tell GS, et al. Plasma total homocysteine and memory in the elderly: the Hordaland Homocysteine Study. Ann Neurol. 2005;58(6):847-857.
40. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188.
41. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558.
42. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task-Force on Alzheimer's disease. Neurology. 1984;34(7):939-944.
43. Silverman JM, Keefe RS, Mohs RC, et al. A study of the reliability of the family history method in genetic studies of Alzheimer disease. Alzheimer Dis Assoc Disord. 1989; 3(4):218-223.
44. 12 concentrations. J Am Geriatr Soc. 2002; 50(1):146-151.
45. Eussen SJ, de Groot LC, Joosten LW, et al. Effect of oral vitamin B-12 with or without folic acid on cognitive function in older people with mild vitamin B-12 deficiency: a randomized, placebo-controlled trial. Am J Clin Nutr. 2006;84(2): 361-370.
46. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd rev ed. Washington, DC: American Psychiatric Association; 1987.
47. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
48. American Psychiatric Association, Task Force on Nomenclature and Statistics. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Washington, DC: American Psychiatric Association; 1980.
49. Fratiglioni L, Grut M, Forsell Y, et al. Clinical diagnosis of Alzheimer's disease and other dementias in a population survey. Agreement and causes of disagreement in applying Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition, criteria. Arch Neurol. 1992; 49(9):927-932.
50. Kivipelto M, Annerbo S, Hultdin J, et al. Homocysteine and holo-transcobalamin and the risk of dementia and Alzheimers disease: a prospective study. Eur J Neurol. 2009;16(7):808-813.
51. Hooshmand B, Solomon A, Kareholt I, et al. Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study. Neurology. 2010;75(16):1408-1414.
52. Smith AD, Refsum H. Vitamin B-12 and cognition in the elderly. Am J Clin Nutr. 2009;89(2):707S-711S.
53. Andres E, Vidal-Alaball J, Federici L, et al. Clinical aspects of cobalamin deficiency in elderly patients. Epidemiology, causes, clinical manifestations, and treatment with special focus on oral cobalamin therapy. Eur J Intern Med. 2007; 18(6):456-462.
54. Allen LH. How common is vitamin B-12 deficiency? Am J Clin Nutr. 2009;89(2):693S-696S.
55. Campbell AK, Miller JW, Green R, et al. Plasma vitamin B-12 concentrations in an elderly Latino population are predicted by serum gastrin concentrations and crystalline vitamin B-12 intake. J Nutr. 2003;133(9):2770- 2776.
56. 12 status in elderly individuals. Aliment Pharmacol Ther. 2008;27(6): 491-497.
57. 12 status in older adults? J Am Med Dir Assoc. 2008;9(3):162-167.
58. Hooshmand B, Solomon A, Kareholt I, et al. Associations between serum homocysteine, holotranscobalamin, folate and cognition in the elderly: a longitudinal study. J Intern Med. 2012;271(2):204-212.
59. 12 concentrations in older people: the Banbury B12 Study. Age Ageing. 2006;35(4):416-422.
60. McCracken C, Hudson P, Ellis R, et al. Methylmalonic acid and cognitive function in the Medical Research Council Cognitive Function and Ageing Study. Am J Clin Nutr. 2006;84(6):1406-1411.
61. McCaddon A, Blennow K, Hudson P, et al. Transcobalamin polymorphism and serum holo-transcobalamin in relation to Alzheimer's disease. Dement Geriatr Cogn Disord. 2004; 17(3):215-221.
62. Refsum H, Smith AD. Low vitamin B-12 status in confirmed Alzheimer's disease as revealed by serum holotranscobala-min. J Neurol Neurosurg Psychiatry. 2003;74(7):959-961.
63. Kristensen MO, Gulmann NC, Christensen JE, et al. Serum cobalamin and methylmalonic acid in Alzheimer dementia. Acta Neurol Scand. 1993;87(6):475-481.
64. Hvas AM, Juul S, Lauritzen L, et al. No effect of vitamin B-12 treatment on cognitive function and depression: a randomized placebo controlled study. J Affect Disord. 2004;81(3):269-273.
65. 12 and folic acid to memory function. Biol Psychiatry. 1970;2(1):19-26.
66. Kwok T, Tang C, Woo J, et al. Randomized trial of the effect of supplementation on the cognitive function of older people with subnormal cobalamin levels. Int J Geriatr Psychiatry. 1998;13(9):611-616.
67. Clarke R, Harrison G, Richards S, et al. Effect of vitamins and aspirin on markers of platelet activation, oxidative stress and homocysteine in people at high risk of dementia. J Intern Med. 2003;254(1):67-75.
68. Ford AH, Flicker L, Alfonso H, et al. Vitamins B(12), B(6), and folic acid for cognition in older men. Neurology. 2010; 75(17):1540-1547.
69. Lewerin C, Matousek M, Steen G, et al. Significant correlations of plasma homocysteine and serum methylmalonic acid with movement and cognitive performance in elderly subjects but no improvement from short-term vitamin therapy: a placebo-controlled randomized study. Am J Clin Nutr. 2005;81(5):1155-1162.
70. Stott DJ, MacIntosh G, Lowe GDO, et al. Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease. Am J Clin Nutr. 2005;82(6):1320-1326.
71. de Jager CA, Oulhaj A, Jacoby R, et al. Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial. Int J Geriatr Psychiatry. 2012;27(6):592-560.
72. McMahon JA, Green TJ, Skeaff CM, et al. A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med. 2006;354(26):2764-2772.
73. Aisen PS, Schneider LS, Sano M, et al. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA. 2008;300(15):1774-1783.
74. Kwok T, Lee J, Law CB, et al. A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people. Clin Nutr. 2011;30(3):297-302.
75. Aisen PS, Andrieu S, Sampaio C, et al. Report of the task force on designing clinical trials in early (predementia) AD. Neurology. 2011;76(3):280-286.
76. de Jager CA, Kovatcheva A. Summary and discussion: methodologies to assess long-term effects of nutrition on brain function. Nutr Rev. 2010;68(suppl 1):S53-S58.
77. 12 and cognition. Nutr Rev. 2010;68(suppl 1):S11-S15.
78. Vellas B, Andrieu S, Sampaio C, et al. Endpoints for trials in Alzheimer's disease: a European task force consensus. Lancet Neurology. 2008;7(5):436-450.
79. Vellas B, Andrieu S, Sampaio C, et al. Disease-modifying trials in Alzheimer's disease: a European task force consensus. Lancet Neurology. 2007;6(1):56-62.
80. Ries ML, Carlsson CM, Rowley HA, et al. Magnetic resonance imaging characterization of brain structure and function in mild cognitive impairment: a review. J Am Geriatr Soc. 2008;56(5):920-934.
81. Resnick SM, Pham DL, Kraut MA, et al. Longitudinal magnetic resonance imaging studies of older adults: a shrinking brain. J Neurosci. 2003;23(8):3295-3301.
82. 12 status and rate of brain volume loss in community-dwelling elderly. Neurology. 2008;71(11):826-832.
83. 12, cognition, and brain MRI measures: a cross-sectional examination. Neurology. 2011;77(13):1276-1282.
84. Smith AD, Smith SM, de Jager CA, et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. Plos One. 2010;5(9):e12244. (doi:10.1371/journal.pone.0012244).